CVClient

今高 寛晃

イマタカ ヒロアキ  (Hiroaki Imataka)

基本情報

所属
兵庫県立大学 工学研究科 教授
学位
農学博士(東京大学)

研究者番号
50201942
J-GLOBAL ID
201801002037126056
researchmap会員ID
B000310027

外部リンク

1.学歴
1979年 三重県立上野高等学校卒業
1979年 東京大学理科2類入学
1983年 東京大学農学部畜産獣医学科卒業
1985年 獣医師免許取得
1988年 東京大学大学院博士課程修了

2.職歴
1988年 東北大学理学部 ポスドク
1990年 京都大学ウイルス研究所ポスドク
1994年 McGill大学医学部 研究員
2002年 理化学研究所 研究員
2008年 兵庫県立大学大学院工学研究科 教授

論文

 93
  • Kodai Machida, Shotaro Noseda, Seraya Miki, Mayumi Yuasa-Sunagawa, Hiroaki Imataka
    The Journal of Antibiotics 78(5) 288-294 2025年3月26日  査読有り
  • Mayuka Hasumi, Hayato Ito, Kodai Machida, Tatsuya Niwa, Tomoya Taminato, Yoshitaka Nagai, Hiroaki Imataka, Hideki Taguchi
    Journal of Biological Chemistry 301(4) 108360-108360 2025年3月  査読有り
  • Akihiro Oguro, Takeshi Uemura, Kodai Machida, Kanata Kitajiri, Ayasa Tajima, Takemitsu Furuchi, Gota Kawai, Hiroaki Imataka
    Journal of Biological Chemistry 108251-108251 2025年1月  査読有り
  • Kodai Machida, Rin Tanaka, Seraya Miki, Shotaro Noseda, Mayumi Yuasa-Sunagawa, Hiroaki Imataka
    BioTechniques 76(4) 161-168 2024年4月  査読有り
    Programmed-1 ribosomal frameshifting (-1 PRF) is a translational mechanism adopted by some viruses, including SARS-CoV-2. To find a compound that can inhibit -1 PRF in SARS-CoV-2, we set up a high-throughput screening system using a HeLa cell extract-derived cell-free protein synthesis (CFPS) system. A total of 32,000 compounds were individually incubated with the CFPS system programmed with a -1 PRF-EGFP template. Several compounds were observed to decrease the -1 PRF-driven fluorescence, and one of them had some suppressive effect on -1 PRF of a SARS-CoV-2 genome sequence in transfected cells. Thus the CFPS system can be used as a tool for a high-throughput screening of chemicals.
  • Hayato Ito, Kodai Machida, Mayuka Hasumi, Morio Ueyama, Yoshitaka Nagai, Hiroaki Imataka, Hideki Taguchi
    Scientific reports 13(1) 22826-22826 2023年12月20日  
    Nucleotide repeat expansion of GGGGCC (G4C2) in the non-coding region of C9orf72 is the most common genetic cause underlying amyotrophic lateral sclerosis and frontotemporal dementia. Transcripts harboring this repeat expansion undergo the translation of dipeptide repeats via a non-canonical process known as repeat-associated non-AUG (RAN) translation. In order to ascertain the essential components required for RAN translation, we successfully recapitulated G4C2-RAN translation using an in vitro reconstituted translation system comprising human factors, namely the human PURE system. Our findings conclusively demonstrate that the presence of fundamental translation factors is sufficient to mediate the elongation from the G4C2 repeat. Furthermore, the initiation mechanism proceeded in a 5' cap-dependent manner, independent of eIF2A or eIF2D. In contrast to cell lysate-mediated RAN translation, where longer G4C2 repeats enhanced translation, we discovered that the expansion of the G4C2 repeats inhibited translation elongation using the human PURE system. These results suggest that the repeat RNA itself functions as a repressor of RAN translation. Taken together, our utilization of a reconstituted RAN translation system employing minimal factors represents a distinctive and potent approach for elucidating the intricacies underlying RAN translation mechanism.

MISC

 7

講演・口頭発表等

 25

共同研究・競争的資金等の研究課題

 21

学術貢献活動

 2